Dr. Joseph Scheeren, Senior Vice President of Bayer Healthcare, China. He started his pharmaceutical career in 1982 with Servier in Paris, responsible for Regulatory Affairs Northern and Eastern Europe; then responsible for Clinical Development in Munich from 1986-1987. He was appointed Head of Worldwide Regulatory Affairs at Serono, Geneva (Switzerland) in 1991. In 1992, he assumed responsibility for Global Regulatory Affairs at Roussel UCLAF. He subsequently headed the Global Marketed Product Regulatory Affairs Department of Hoechst Marion Roussel. Dr. Scheeren joined Bayer Pharmaceuticals as Senior Vice President, Head of Global Regulatory Affairs, responsible for development in the US, in 2004; in 2009, he became Site Head US in Montville, NJ. He became Head of Global Development Asia in Beijing in 2012, and was appointed Head of Global Regulatory Affairs Pharma and Consumer Care of Bayer Healthcare, Basel (Switzerland) in 2015.Dr. Scheeren serves on Advisory Boards for the Center for Innovation in Regulatory Science, SAFE-PHARMA, the Regulatory Affairs track at Yale University, the Center of Regulatory Excellence Singapore, the Research & Development-based Pharmaceutical Association in China, and the China Core Research and Development Committee. He has served as Chairman of the DIA Regional Advisory Council for Europe, Middle East & Africa; he is also a foreign member of the Academie Nationale de Pharmacie, France, and a lecturer at Yale University. Dr. Scheeren studied pharmacy at the University of Leiden.